Author Page for Mariona Parera

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Number of pages: 31 Posted: 28 Aug 2024

Carlos Blazquez-Bondia, Francesc Català-Moll, Ferrán Torres, Christian Manzardo, Eva Bonfill, Vicenç Falcó, Pere Domingo, Daniel Podzamczer, Lluís Force, Adrià Curran, Mariona Parera, Maria Casadellà, Jose M. Miró, Marc Noguera-Julian and Roger Paredes

Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Universitat Autònoma de Barcelona (UAB), Universidad de Barcelona - Hospital Clínic Barcelona, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Infectious Disease Department, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Bellvitge University Hospital, Hospital de Mataró, Autonomous University of Barcelona - Infectious Disease Department, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, University of Barcelona - Hospital Clinic, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa and Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department

Downloads 143 (518,518)

Abstract:

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Number of pages: 31 Posted: 05 Sep 2024

Carlos Blazquez-Bondia, Francesc Català-Moll, Ferrán Torres, Christian Manzardo, Eva Bonfill, Adrià Curran, Pere Domingo, Daniel Podzamczer, Lluís Force, Vicenç Falcó, Mariona Parera, Maria Casadellà, Jose M. Miró, Marc Noguera-Julian and Roger Paredes

Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Josep Carreras Research Institute (IJC) - Epigenetics and Immune Disease Group, Universitat Autònoma de Barcelona (UAB), Universidad de Barcelona - Hospital Clínic Barcelona, Hospital Clínic de Barcelona, Autonomous University of Barcelona - Infectious Disease Department, Hospital de la Santa Creu i Sant Pau - Infectious Diseases Unit, Bellvitge University Hospital, Hospital de Mataró, Autonomous University of Barcelona - Infectious Disease Department, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa, University of Barcelona - Hospital Clinic, Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa and Hospital Universitari Germans Trias i Pujol - Infectious Diseases Department

Downloads 80 (826,467)

Citation 1

Mariona Parera

Hospital Germans Trias y Pujol (ICO-IJC) - Institut de Recerca de la Sida. IrsiCaixa

1

223

1

Scholarly Papers (1)

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Abstract:

Gut Microbiota Recovery in Late Hiv-1 Presenters Initiating First-Line Dolutegravir-Based Antiretroviral Therapy: Results from a 2-Year, Open-Label, Randomized Clinical Trial

Abstract: